Geron reported $522.34M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Amgen USD 27.88B 1.15B Sep/2025
Bio Techne USD 609.51M 1.21M Sep/2025
Cassava Sciences USD 108.91M 5.91M Sep/2025
Cytokinetics USD 977.35M 90.81M Sep/2025
Exelixis USD 1.4B 221.5M Sep/2025
Genmab DKK 3.91B 127M Jun/2025
Geron USD 522.34M 16.75M Sep/2025
Gilead Sciences USD 18.84B 4.12B Sep/2025
Incyte USD 4.28B 634.19M Sep/2025
MacroGenics USD 232.09M 27.15M Sep/2025
Novartis USD 28.2B 2.26B Sep/2025